Literature DB >> 8781705

Intravenous immunoglobulin replacement therapy for common variable immunodeficiency during pregnancy.

H Osada1, Y Morikawa, T Nishiwaki, S Sekiya.   

Abstract

Patients with common variable immunodeficiency (CVID), characterized by impaired antibody production, have a high susceptibility to bacterial infections and need supplements of immunoglobulin G (IgG). We report two pregnancies in a woman with CVID. Differences in the outcome of the two pregnancies suggest the need for adjustment of replacement therapy during pregnancy.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8781705     DOI： 10.1007/s004040050118

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


  10 in total

1.  IgG replacement therapy for primary hypogammaglobulinaemia during pregnancy: report of 9 pregnancies in 4 patients.

Authors:  P E Williams; C L Leen; A D Heppleston; P L Yap
Journal:  Blut       Date:  1990-03

Review 2.  Intravenous gamma-globulin in pregnancy: a review.

Authors:  R A Sacher; J C King
Journal:  Obstet Gynecol Surv       Date:  1989-01       Impact factor: 2.347

3.  Common variable hypogammaglobulinemia in pregnancy: treatment with high-dose immunoglobulin infusions.

Authors:  D L Madsen; V A Catanzarite; F Varela-Gittings
Journal:  Am J Hematol       Date:  1986-03       Impact factor: 10.047

4.  Hypogammaglobulinaemia during pregnancy in identical twin sisters.

Authors:  Z O Amarin; K A Grant
Journal:  Int J Gynaecol Obstet       Date:  1982-12       Impact factor: 3.561

5.  High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.

Authors:  C M Roifman; H Levison; E W Gelfand
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

6.  Intravenous immunoglobulin in pregnancy.

Authors:  C I Smith; L Hammarström
Journal:  Obstet Gynecol       Date:  1985-09       Impact factor: 7.661

7.  Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases.

Authors:  H D Ochs; S H Fischer; R J Wedgwood; D W Wara; M J Cowan; A J Ammann; A Saxon; M D Budinger; R U Allred; R H Rousell
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

8.  Use of intravenous immune globulin in pregnant women with common variable hypogammaglobulinemia.

Authors:  R U Sorensen; J W Tomford; M T Gyves; N E Judge; S H Polmar
Journal:  Am J Med       Date:  1984-03-30       Impact factor: 4.965

Review 9.  NIH conference. New insights into common variable immunodeficiency.

Authors:  M C Sneller; W Strober; E Eisenstein; J S Jaffe; C Cunningham-Rundles
Journal:  Ann Intern Med       Date:  1993-05-01       Impact factor: 25.391

Review 10.  Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature.

Authors:  F M Schaffer; J A Newton
Journal:  J Perinatol       Date:  1994 Mar-Apr       Impact factor: 2.521
  10 in total
  6 in total

1.  Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women.

Authors:  A Gardulf; E Andersson; M Lindqvist; S Hansen; R Gustafson
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

2.  Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration.

Authors:  Maria Giovanna Danieli; Romina Moretti; Lucia Pettinari; Simona Gambini
Journal:  BMJ Case Rep       Date:  2012-12-17

3.  Pregnancy Outcome in Patients with Common Variable Immunodeficiency.

Authors:  Pavlina Kralickova; Barbora Kurecova; Ctirad Andrys; Irena Krcmova; Dalibor Jilek; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

4.  Fertility, pregnancies and outcomes reported by females with common variable immune deficiency and hypogammaglobulinemia: results from an internet-based survey.

Authors:  Adi V Gundlapalli; Christopher Scalchunes; Marcia Boyle; Harry R Hill
Journal:  J Clin Immunol       Date:  2015-01-09       Impact factor: 8.317

5.  Does the Maternal Serum IgG Level during Pregnancy in Primary Antibody Deficiency Influence the IgG Level in the Newborn?

Authors:  Vasantha Nagendran; Noel Emmanuel; Amolak S Bansal
Journal:  Case Reports Immunol       Date:  2015-08-27

6.  Pregnancy, child bearing and prevention of giving birth to the affected children in patients with primary immunodeficiency disease; a case-series.

Authors:  Saba Sheikhbahaei; Roya Sherkat; Nadezhda Camacho-Ordonez; Razie Khoshnevisan; Asadollah Kalantari; Mansour Salehi; Seyed Saman Nazemian; Mohammad Hossein Nasr-Esfahani; Christophe Klein
Journal:  BMC Pregnancy Childbirth       Date:  2018-07-11       Impact factor: 3.007
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.